Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 14/20 | 0.48 |
| ▸ | BCHE | P06276 | 8/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | APP | P05067 | 1/20 | 0.34 |
| ▸ | IDO1 | P14902 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19601088 | 0.96 | ACHE (0.54) | ACHEBCHECA12CA1CA2 | |
| SCHEMBL19607289 | 0.88 | ACHE (0.43) | ACHEBCHECA12CA1CA2 | |
| SCHEMBL19601120 | 0.87 | ACHE (0.54) | ACHEBCHECA12CA1CA2 | |
| SCHEMBL19601137 | 0.84 | PTGS2 (0.40) | ACHEBCHE | |
| SCHEMBL19601082 | 0.82 | ACHE (0.43) | ACHECA12CA1CA2CA9 | |
| SCHEMBL19601105 | 0.82 | ACHE (0.55) | ACHEBCHECA12CA1CA2 | |
| SCHEMBL19601135 | 0.80 | ESR2 (0.36) | ACHECA12CA1CA2CA9 | |
| SCHEMBL19607342 | 0.75 | SLC22A2 (0.41) | ACHECA12CA1CA2CA9 | |
| SCHEMBL19607239 | 0.75 | L3MBTL1 (0.36) | ACHECA12CA1CA2CA9 | |
| SCHEMBL19607237 | 0.75 | TRPA1 (0.34) | ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10310350-B2 | Organic compound, electrochromic compound, and electrochromic element, optical filter, lens unit, imaging device, and window component having same | CANON KABUSHIKI KAISHA (JP) | 2019-06-04 | — | — | US | disclosed |
| US-20170329195-A1 | ORGANIC COMPOUND, ELECTROCHROMIC COMPOUND, AND ELECTROCHROMIC ELEMENT, OPTICAL FILTER, LENS UNIT, IMAGING DEVICE, AND WINDOW COMPONENT HAVING SAME | CANON KABUSHIKI KAISHA (JP) | 2017-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10310350-B2 | Organic compound, electrochromic compound, and electrochromic element, optical filter, lens unit, imaging device, and window component having same | KCNJ2, KCNH3, KCNN2 | ACHE 416/4885BCHE 2668/4885CA12 496/4885 |
| US-20170329195-A1 | ORGANIC COMPOUND, ELECTROCHROMIC COMPOUND, AND ELECTROCHROMIC ELEMENT, OPTICAL FILTER, LENS UNIT, IMAGING DEVICE, AND WINDOW COMPONENT HAVING SAME | KCNJ2, KCNH3, KCNN2 | ACHE 416/4885BCHE 2668/4885CA12 496/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.